Resolute Kirsty

Resolute’s Kirsty Mearns promoted

pharmafile | January 14, 2010 | Appointment | Medical Communications Resolute, appointment, medical communications 

Resolute has promoted Kirsty Mearns to the role of director, joining the PR agency’s board.

“I am incredibly pleased and very proud to have been promoted to this position,” said Kirsty. “I am looking forward to working with the rest of the board to drive Resolute’s continued growth and success in the coming years”.

After joining Resolute in 2006 as an account director, Kirsty was swiftly promoted to associate director and team leader in 2008.

Advertisement

She continues to contribute significantly to the company’s new business success and leads diverse accounts for DePuy, GSK, Pfizer, Shire and ViiV Healthcare.

Kirsty graduated from Oxford University with an MBiochem in Molecular and Cellular Biochemistry.

“Kirsty is a rare talent,” said Paul Blackburn, Resolute joint chief executive. “She combines a sharp business mind with creative, strategic thinking and an ability to inspire and lead her teams that is hard to match.”

Related Content

Men’s health – a new report from the Department of Health and Social Care

The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

The Gateway to Local Adoption Series

Latest content